Although AFAP1L2 is also associated with tumor progression, such as prostate cancer [11], non-small cell lung cancer [12] and breast cancer [13], AFAP1L2 acts as a tumor suppressor in carcinogen-induced skin tumorigenesis [14]. This evidence concerns the gene AFAP1L2 and prostate carcinoma.